trending Market Intelligence /marketintelligence/en/news-insights/trending/2jkmcmigxcgyimgfpygnya2 content esgSubNav
In This List

Actinium Pharmaceuticals appoints chief commercial officer

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Actinium Pharmaceuticals appoints chief commercial officer

Actinium Pharmaceuticals Inc. appointed Anil Kapur chief commercial officer, effective Feb. 8.

Most recently, Kapur worked at Bristol-Myers Squibb Co. as vice president, head of early assets, biomarkers and external innovation, worldwide oncology commercialization.